LENZ Insider Trading

Insider Ownership Percentage: 38.40%
Insider Buying (Last 12 Months): $15,501,073.95
Insider Selling (Last 12 Months): $0.00

LENZ Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at LENZ Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10M$0$10MTotal Insider BuyingTotal Insider Selling

LENZ Therapeutics Share Price & Price History

Current Price: $23.82
Price Change: Price Increase of +1.32 (5.87%)
As of 01/21/2025 05:00 PM ET

This chart shows the closing price history over time for LENZ up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MarAprMayJunJulAugSepOctNovDecJan$23.82Closing price on 01/21/25:

LENZ Therapeutics Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for LENZ Therapeutics (NASDAQ:LENZ)

54.32% of LENZ Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LENZ by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$1.07Mbought$89ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100M-$50M$0$50M$100MTotal InflowsTotal Outflows
LENZ Therapeutics logo
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
Read More on LENZ Therapeutics

Today's Range

Now: $23.82
Low: $22.62
High: $24.29

50 Day Range

MA: $31.24
Low: $22.36
High: $37.37

52 Week Range

Now: $23.82
Low: $14.42
High: $38.93

Volume

142,928 shs

Average Volume

178,344 shs

Market Capitalization

$655.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57

Who are the company insiders with the largest holdings of LENZ Therapeutics?

LENZ Therapeutics' top insider investors include:
  1. Ra Capital Management, LP (Director)
  2. James W Mccollum (Director)
Learn More about top insider investors at LENZ Therapeutics.

Who are the major institutional investors of LENZ Therapeutics?

LENZ Therapeutics' top institutional investors include:
  1. Harbor Capital Advisors Inc. — 0.16%
  2. Kelleher Financial Advisors — 0.06%
  3. SG Americas Securities LLC — 0.02%
Learn More about top institutional investors of LENZ Therapeutics stock.

Which institutional investors are selling LENZ Therapeutics stock?

In the last quarter, LENZ stock was sold by these institutional investors:
  1. Kelleher Financial Advisors

Which institutional investors are buying LENZ Therapeutics stock?

During the previous quarter, LENZ stock was purchased by institutional investors including:
  1. Harbor Capital Advisors Inc.
  2. SG Americas Securities LLC
Within the last year, these company insiders have bought LENZ Therapeutics stock:
  1. Ra Capital Management, LP (Director)
  2. James W Mccollum (Director)
Learn More investors buying LENZ Therapeutics stock.